Southeast Asia Covid-19 Vaccine Tracker: Who Gets What, When
Southeast Asia Covid-19 Vaccine Tracker: Who Will Get What, When
(Bloomberg) -- In the evolving race for Covid-19 vaccines, Indonesia has taken the apparent lead in Southeast Asia with the delivery of vaccines from China’s Sinovac Biotech Ltd. this month.
Southeast Asia’s biggest and most populous economy has also announced multiple agreements to receive potential vaccines, as the nation fights the worst coronavirus outbreak in the region.
Yet when it comes to the Pfizer Inc.-BioNTech SE vaccine that has been bolstered by U.K. and U.S. regulatory approvals, smaller but wealthier Singapore has the advantage -- it expects the first shipments by the end of December.
Both countries are also involved in vaccine development and manufacturing, a testament to the variety of strategies employed across the region. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccine strategies.
INDONESIA | |
Strategy | Indonesia needs about 246 million doses to vaccinate 107 million people aged 18 to 59 years old.
|
Timeline | 4Q 2020: Sinovac
|
PHILIPPINES | |
Strategy | The country wants to have at least 50 million vaccine shots next year to inoculate about a fourth of the population, the bulk of which will likely arrive by the end of 2021 or early 2022. Priority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.
|
Timeline | 1Q 2021: Sinovac, Sputnik V
May 2021: AstraZeneca
|
MALAYSIA | |
Strategy | The country seeks to buy shots for 70% of its population, more than double the current 30% coverage, Prime Minister Muhyiddin Yassin said this month. It also plans to tap the Covax facility to provide vaccines for 10% of the population while reaching out to 10 companies with vaccines that are at phase-III clinical trials.
|
Timeline | 1Q 2021: Pfizer
|
SINGAPORE | |
Strategy | The city-state has set aside roughly $750 million for vaccines, tapping the likes of Arcturus Therapeutics Holdings Inc., Moderna Inc., Pfizer and Sinovac for supplies. It estimates there will be enough doses for its population by the third quarter of 2021, and will be able to offer vaccinations for the entire population of more than 5 million by the end of next year.
|
Timeline | 4Q 2020: Pfizer
Early 2021: Arcturus
|
THAILAND | |
Strategy | Thailand wants to inoculate about 50% of its population by next year. It plans to get 26 million doses from the World Health Organization-backed Covax program, 26 million from AstraZeneca, and 13 million more from other sources, providing immunity to more than 30 million people. Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot.
|
Timeline | Mid-2021: AstraZeneca
|
VIETNAM | |
Strategy | The country is working on developing vaccines and will work with suppliers when vaccines are available, according to a spokeswoman at the foreign affairs ministry.
|
©2020 Bloomberg L.P.